| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.089 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |